Search NLS News

More than 18,000 delegates from 85 countries are attending the event in Boston, USA. The BIO International Convention offers intensive networking to discover new opportunities and promising partnerships. The program includes areas like therapeutic frontiers, the business of biotech, regulatory and policy outlooks, and human capital. Stay updated on nordiclifescience.org for more BIO-updates from Ola Björkman! […]

Devyser’s Deputy CEO and founder Ulf Klangby will leave his position within the company for an advisory role as a consultant as of July 1, 2023. Ulf Klangby will leave his operational role as part of the group management team and instead support the company as a consultant. In his consulting role, Ulf will support […]

Corporate social responsibility (CSR) has become an integral part of business operations in the Nordic region, with companies prioritizing sustainable practices and demonstrating a commitment to social and environmental responsibility. Nordic companies have been at the forefront of CSR practices, setting the benchmark for other regions to follow, with many companies making significant investments in […]

Qlucore has presented the first results from an EU-funded project for improved diagnosis of lung cancer. The presented results, a new classification model, not only separates different subgroups of primary lung cancer but also indicates whether the tumor sample is a metastasis of breast, colorectal, or kidney cell cancer. This information can have significant implications […]

InDex Pharmaceuticals has announced that a license agreement has been signed with Viatris Pharmaceutical Japan to register and commercialize cobitolimod in Japan for the treatment of ulcerative colitis. “We are excited to start our collaboration with Viatris Japan with the common goal to register and commercialize cobitolimod for the Japanese market. Viatris Japan shares our […]

A national COVID-19 biobank sample collection has been added to the COVID-19 Sample Collection Database, which is available through the Swedish Pandemic Preparedness Portal. This collection includes over 1.5 million samples that are available for use in research. The samples were collated as part of a collaboration between Swedish regional health agencies, the National Pandemic […]

Oncopeptides has been informed that the preliminary investigation by the Swedish Economic Crime Authority of the company’s Chief Scientific Officer and former CEO, Jakob Lindberg, has been terminated. In their decision, the Swedish Economic Crime Authority writes that there is no longer a reason to complete the preliminary investigation as “the investigative material available [does […]

Affibody has announced the appointment of Peter Zerhouni as Chief Business Officer (CBO). He will join the Affibody management team and will be responsible for business and corporate development. This appointment strengthens the leadership of key corporate functions as the company enters its next stage of development, states the company. “We are pleased to welcome […]

Evaxion Biotech to present promising clinical data from its EVX-01 Phase 1 clinical trial in metastatic melanoma at the 2023 ASCO annual meeting. “We are excited to report that the EVX-01 Phase 1 trial achieved its primary objectives. EVX-01 was well tolerated and induced a higher objective response rate than previously reported for standard of […]

ProPharma announces new office located in Ideon Science Park, effective on June 1, 2023. Ideon Science Park provides abundant opportunities and accessibility for individuals in the Öresund region, encompassing Lund, Malmö, and Copenhagen, describes the company. As members of the Medicon Village Alliance, ProPharma colleagues will have the advantage of actively engaging in events, meetings, […]